OncoSec Medical Inc (ONCSQ)

[trading.jeff]

Dr. Pierce transitions from CSO to consultant effective tomorrow:

Robert H. Pierce, MD, Chief Scientific Officer, will serve as Chief Scientific Strategist and Chairman of the Scientific Advisory Board effective June 18, 2016. In this newly created position, Dr. Pierce will continue to guide the scientific strategy of OncoSec's immuno-oncology platform and identify strategic opportunities with greatest need and best suited for the Company's technology. He will also have the responsibility for reviewing clinical safety and efficacy data to provide medical and strategic guidance to advance the Company's product pipeline. At that time, Dr. Pierce will transition from Chief Scientific Officer to consultant.

Dr. Pierce stated, "This transition will allow me to provide strategic oversight on a very robust and versatile platform that I helped to build, while allowing me to explore broader applications and additional underpinnings of immuno-oncology in other professional contexts. I am enthusiastic about the platform we have created and the progress we have made in advancing our clinical pipeline, and I believe the data we generate will continue to demonstrate our leadership in this field."

http://ir.oncosec.com/press-releases/detail/1863/oncosec-announces-new-senior-leadership-responsibilities

$ONCS